Firdapse
Firdapse is a medicine authorised by Swissmedic under authorisation number 61853. The authorisation holder is DRAC AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 August 2012 and the authorisation is valid without a time limit. ATC code N07XX05 places the medicine in the group Other nervous system drugs.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Firdapse, Tabletten | B | 22 August 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | Tablette(n) | N07XX05 | 01.14.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Firdapse authorised in Switzerland?
Yes. Firdapse is authorised by Swissmedic under authorisation number 61853, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Firdapse have?
Firdapse is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Firdapse?
The authorisation holder is DRAC AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.